{"schema_version":"secwatch.filing_event.v1","accession":"0001413329-22-000137","form_type":"8-K","ticker":"PM","cik":"0001413329","company_name":"Philip Morris International Inc.","filed_at":"2022-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.529628+00:00","generated_at":"2026-06-21T04:41:08.911607+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Philip Morris appoints Jorge Insuasty President of Vectura Fertin Pharma; adjusts de Wilde's compensation","bullets":["Jorge Insuasty appointed full-time President, Vectura Fertin Pharma effective Jan 1, 2023; continues reporting to CEO Jacek Olczak.","Insuasty steps down as Chief Life Sciences Officer; Badrul Chowdhury now reports directly to CEO as Chief Life Sciences Officer, Smoke-Free Products.","Frederic de Wilde appointed President of SSEA, CIS, MEA region; base salary increased to CHF 1,000,008 (approx. $1,080,009).","de Wilde's annual incentive target set at 125% of base salary; equity award target at 275% of base salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001413329-22-000137","json":"https://secwatch.observer/filing/0001413329-22-000137.json","markdown":"https://secwatch.observer/filing/0001413329-22-000137.md","text":"https://secwatch.observer/filing/0001413329-22-000137.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/0001413329-22-000137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/pm-20221208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T04:41:08.911607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8c04c3b554","claim":"Frederic de Wilde was appointed as President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region at Philip Morris International Inc..","evidence_excerpt":"Frederic de Wilde, currently President, European Union Region, will be appointed President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/0001413329-22-000137-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region"}],"fact_type":"executive_change"},{"claim_id":"f4812221dd","claim":"Jorge Insuasty was appointed as President, Vectura Fertin Pharma at Philip Morris International Inc..","evidence_excerpt":"On December 8, 2022, the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company”) approved the appointment of Jorge Insuasty as the full-time President, Vectura Fertin Pharma, effective January 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/0001413329-22-000137-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Vectura Fertin Pharma"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}